Dr. Joshua Milner, an allergist and immunologist who has made key discoveries into the origin of previously unidentified disorders that affect children and families, has been awarded the second annual Gale and Ira Drukier Prize in Children’s Health Research.
Bridge Medicines, a pioneering drug discovery company focused on advancing promising early technologies from concept to clinic, announced today the appointment of William J. Polvino, M.D., as Chief Executive Officer.
Scalp cooling can lessen some chemotherapy-induced hair loss – one of the most devastating hallmarks of cancer – in certain breast cancer patients, according to a new multicenter study from UC San Francisco, Weill Cornell Medicine and three other medical centers.
Dr. Virginia Pascual, a renowned physician-scientist specializing in pediatric rheumatology, has been appointed the founding Gale and Ira Drukier Director of the Gale and Ira Drukier Institute for Children’s Health.
Dr. Augustine M.K. Choi, an internationally renowned physician-scientist in the field of lung disease, has been named the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and Cornell University’s provost for medical affairs.
A new study has found that the rate of prostate biopsies and radical prostatectomies decreased following a 2012 United States Preventative Task Force recommendation against prostate specific antigen testing.